GSK-2334470 25 mg | ≥99% LKT Laboratories, Inc. PI3K and PDK1 inhibitor. More Information Supplier Page × GSK-2334470
GSK-2334470 5 mg | ≥99% LKT Laboratories, Inc. PI3K and PDK1 inhibitor. More Information Supplier Page × GSK-2334470
GSK-2334470 1 mg | ≥99% LKT Laboratories, Inc. PI3K and PDK1 inhibitor. More Information Supplier Page × GSK-2334470
GSK-126 5 mg | ≥99% LKT Laboratories, Inc. EZH2 HMT inhibitor. More Information Supplier Page × GSK-126
GSK-126 1 mg | ≥99% LKT Laboratories, Inc. EZH2 HMT inhibitor. More Information Supplier Page × GSK-126
BYL719 25 mg | ≥99% LKT Laboratories, Inc. p110α PI3K inhibitor. More Information Supplier Page × BYL719
Borrelidin 500 µg | ≥98% LKT Laboratories, Inc. Macrolide; threonyl-tRNA synthetase/ligase inhibitor. More Information Supplier Page × Borrelidin
LY-294002 100 mg | ≥99% LKT Laboratories, Inc. PI3K inhibitor. More Information Supplier Page × LY-294002
LY-294002 25 mg | ≥99% LKT Laboratories, Inc. PI3K inhibitor. More Information Supplier Page × LY-294002
LY-294002 5 mg | ≥99% LKT Laboratories, Inc. PI3K inhibitor. More Information Supplier Page × LY-294002
